Abstract The adenomatous polyposis coli (APC) gene is known to act as a tumor suppressor gene in both sporadic and hereditary colorectal cancer by negatively regulating WNT signaling. Familial adenomatous polyposis (FAP) patients develop intestinal polyps due to the presence of a single germline mutation in APC. The severity of the FAP phenotype is a function of the position of the APC mutation, indicating a complex role for APC that extends beyond the canonical WNT pathway. APC encodes a large protein with multiple functional domains, including an armadillo repeat domain that has been linked to protein-protein interactions. To determine the effect of the armadillo repeat domain on intestinal tumorigenesis, we generated a congenic mouse line (Apc D242 ) carrying a gene trap cassette between exons 7 and 8 of the murine Apc gene. Apc D242/? mice express a truncated Apc product lacking the armadillo repeat domain as part of a fusion protein with b-geo. Expression of the fusion product was confirmed by X-gal staining, ensuring that Apc D242 is not a null allele. In contrast, Apc Min/? mice produce a truncated Apc product that contains an intact armadillo repeat domain. On the C57BL/6J background, Apc D242/? mice develop more polyps than do Apc Min/? mice along the entire length of the small intestine; however, polyps were significantly smaller in Apc D242/? mice. In addition, polyp multiplicity in Apc D242/? mice is affected by polymorphisms between inbred strains. These data suggest that the armadillo repeat domain of the Apc protein suppresses tumor initiation in the murine intestine while also promoting tumor growth.
Introduction
Colorectal cancer has the third highest mortality rate for cancers among men and women in the United States, accounting for 9-10% of total cancer-related deaths (www. cancer.org). Genetic evidence suggests that the APC gene acts as a classical tumor suppressor gene in both sporadic and hereditary colorectal cancers, with inactivation of both alleles resulting in tumor growth (Miyaki et al. 1994; Powell et al. 1992) . Inactivation of APC results in nuclear localization of b-catenin and subsequent activation of the WNT signaling pathway (MacDonald et al. 2009 ). Familial adenomatous polyposis (FAP) is a dominantly inherited disorder in which individuals inherit one defective APC allele. The presence of a mutated APC allele makes FAP patients susceptible to the development of colorectal adenomas following inactivation of the remaining wild-type APC allele through somatic mutation and/or loss of heterozygosity (LOH) (Groden et al. 1991; Kinzler et al. 1991; Nishisho et al. 1991) . As a result, FAP patients are diagnosed by the development of hundreds to thousands of benign adenomatous polyps throughout the intestinal tract.
The study of human diseases, such as FAP, has been greatly facilitated by the use of animal model systems. Mouse models provide a fixed genetic background and controlled environment in which to analyze the cellular processes leading to neoplasia (Thompson et al. 2004 ). Several models of intestinal tumorigenesis have been generated by introducing specific mutations into the murine ortholog of the APC gene (Apc), allowing investigation of its role in both polyp initiation and carcinoma progression (reviewed in Siracusa et al. 2004; Uronis and Threadgill 2009) . The most extensively studied of these models is the multiple intestinal neoplasia (Apc Min ) mouse, which was discovered through phenotypic screening following ENU mutagenesis (Moser et al. 1990 ). B6 mice carrying the Apc Min mutation develop an average of 106 benign adenomas throughout the length of the intestinal tract. Apc is a large, multidomain protein and the position of a mutation can affect polyp number, location, and stage in mice (Heyer et al. 1999; Taketo and Edelmann 2009 , results in greatly reduced tumor burden (Fodde et al. 1994; Oshima et al. 1995) . These data recapitulate findings from FAP patients in which tumor multiplicity and secondary symptoms correlate with the location of the germline APC mutation (Burt and Jasperson 2008 
Histopathological analysis of tumors
Tissues were fixed in Formalde-Fresh 10% buffered formalin solution (Fisher Scientific) overnight at 4°C and stored in 70% EtOH. Fixed tissues were embedded in paraffin and tissues were cut and mounted on glass slides by the KCC Translational Research Core Facility. Tissues were stained with eosin and counterstained with hematoxylin. Staining was visualized on a Nikon Eclipse E600 microscope at either 49 or 209 magnification.
Results

Generation of a mouse strain carrying an Apc gene trap allele
The APC gene is mutated in both sporadic colorectal cancers and hereditary disorders such as FAP. To study the effects of the armadillo repeat domain of the Apc protein on intestinal tumorigenesis, a mouse model expressing a truncated Apc protein was generated. BayGenomics generated a library of ES cell clones using a randomly inserted gene trap vector (Stryke et al. 2003) . The gene trap cassette carries a splice acceptor site, a sequence encoding the b-geo fusion protein, and a polyadenylation site (Fig. 1a) . Insertion of the cassette into an intronic sequence results in the fusion of the N-terminus of the trapped gene to the b-geo protein. One clone (XA018) carried a cassette inserted between exons 7 and 8 of the Apc gene (Fig. 1a) . The Apc gene consists of 16 exons, with the majority of the open reading frame (ORF) encoded by exon 16 (www. ensemble.org). Different Apc mutations result in different polyposis phenotypes in both FAP patients and mouse models (reviewed in Aoki and Taketo 2007) . Therefore, we generated a congenic mouse strain carrying the Apc Gt(XA018)Byg allele (Apc D242 ) to analyze the effect of this novel Apc mutation on intestinal tumorigenesis. XA018 ES cells were injected into C57BL/6J (B6) blastocysts. The resulting chimeric offspring were genotyped for the presence of the gene trap cassette (Fig. 1b) and mice carrying the Apc D242 allele were backcrossed to the B6 inbred strain for more than ten generations to generate a congenic line.
The Apc D242 allele generates an Apc fusion protein with b-galactosidase Apc encodes a 2842-amino-acid protein containing multiple functional domains, including an N-terminal oligomerization domain and an armadillo repeat domain involved in protein-protein interactions (Fig. 2) . The presence of the gene trap cassette in Apc D242/? mice results in the splicing of the first seven exons of Apc to the b-geo gene. The Apc D242 allele generates a theoretical 172-kDa fusion product combining the first 241 residues of the Apc protein with the full-length b-geo protein (Fig. 2) . The b-geo protein contains the functional domains of both the b-galactosidase enzyme and a neomycin resistant protein.
To confirm expression of the mutant fusion protein, X-gal staining was performed on samples from the distal small intestine and distal colon of Apc D242/? mice. Tissues from Apc D242/? mice stained blue, while those of wild-type littermates did not stain blue, indicating the presence of functional b-galactosidase activity in the Apc D242/? intestinal tract and expression of the mutant allele (Fig. 3) .
Apc
D242/? mice develop adenomas in the small intestine and colon
The most prominent phenotype resulting from Apc mutations is intestinal tumorigenesis. To identify how the Apc D242 mutation affects polyposis, the intestinal tracts of Apc D242/? mice were evaluated for the presence of polyps at 120 days of age. These mutant mice had an average of 177 ± 30 polyps throughout the length of the intestinal tract. The polyp multiplicity of Apc D242/? mice is significantly higher than the polyp multiplicity of B6 Apc Min/?
mice (106 ± 28, P \ 0.001). Analysis of tumor distribution indicates that this increased tumorigenesis occurs along the entire length of the small intestine, but not in the colon (Fig. 4a) . Apc D242/? mice had significantly smaller polyps in all areas of the small intestine (Fig. 4b) . Both polyp multiplicity and polyp size contribute to overall tumor burden, a measurement that negatively correlates with mortality in mouse models of intestinal tumorigenesis (Guillen-Ahlers et al. 2010; Korsisaari et al. 2007) . Despite the decrease in polyp size, Apc D242/? mice have a significantly increased tumor burden in the distal small intestine compared to B6 Apc Min/? controls (Fig. 4c) . mice. A PCR product of *300 bp is produced hematoxylin and eosin (H&E). H&E staining showed no invasion through the basement membrane in tumors from either model (Fig. 5a-d (Fig. 6) . The percent decrease in polyp number due to the introduction of the C3H background was 86% in both Apc D242/? and Apc Min/? mice. These data indicate that the modifiers of Apc Min -mediated tumorigenesis found in the C3H inbred strain are also capable of modifying the phenotype of the Apc D242 allele.
Discussion
Numerous mouse models have been generated to study the role of the Apc gene in tumor initiation, growth, and progression in the intestinal tract. Many of these models carry Apc mutations that result in truncated proteins of varying sizes (Heyer et al. 1999; Taketo and Edelmann 2009 ).
Comparison of polyp multiplicity, distribution, size, and stage between these Apc mutant mice can be used to dissect the functions of the various domains contained in Apc. Apc Min/? mice, a common model of familial adenomatous polyposis (FAP), carry a point mutation in codon 850 that results in a premature stop codon and a truncated protein product (Fig. 2) mice, however, were generated on a mixed genetic background and were never made congenic on the B6 background (Kuraguchi et al. 2006) . Different inbred backgrounds are known to harbor modifier genes that can alter the incidence, size, and stage of intestinal tumors (reviewed in Kwong and Dove 2009 mice are maintained on a B6 background and develop an average of 122 intestinal polyps; however, the truncated Apc protein expressed from the Apc D474 allele still carries a portion of the armadillo repeat domain (Fig. 2) (Sasai et al. 2000) .
In The majority of APC mutations identified in patients fall within a region between codons 1286 and 1513, known as the mutation cluster region (MCR) (Aoki and Taketo 2007; Fearnhead et al. 2001; Miyoshi et al. 1992) . MCR mutations result in C-terminal truncation proteins that are lacking the domains required for formation of the negative regulatory complex and degradation of b-catenin (Aoki and Taketo 2007) . The presence of the MCR suggests a strong pressure selecting not only for loss of the C-terminus of Apc, but also retention of the N-terminus. Takacs et al. (2008) demonstrated that Apc proteins lacking the C-terminus upregulate signaling through the Wnt pathway in Drosophila melanogaster. Mutations in the MCR may, therefore, combine loss of the potent tumor suppressor function of Apc with the generation of an oncogenic truncated protein.
The disruption of the role of APC as a tumor suppressor in colorectal tumors has been extensively studied. The mechanism by which truncated APC may act as an oncogene, however, is still poorly understood. Truncated proteins resulting from MCR mutations retain the armadillo repeat and the oligomerization domains, both of which have potentially oncogenic functions. Apc Min/? mice carry a mutation at codon 850 and produce a truncated Apc protein that also carries these two domains. The Apc D242 product, however, contains only the oligomerization domain (Fig. 2) . Apc D242/? mice develop significantly more polyps than Apc Min/? mice and FAP patients with mutations similar to that of Apc D242 present with a severe form of the disease (Nugent et al. 1994) . These data indicate that the Apc D242 mutation successfully mimics the human disease phenotype and suggest that loss of the armadillo repeats results in increased tumorigenesis. The molecular mechanism behind this increased tumorigenesis in both mice and humans remains unknown. Fig. 4 Comparison of polyp location, size, and tumor burden in Apc Min/? and Apc D242/? mice at 120 days of age. a Average polyp numbers detected in the proximal, middle, and distal portions of the small intestine and colon. b Average polyp sizes detected in the proximal, middle, and distal portions of the small intestine and colon. Diameters of polyps were measured and reported in mm. c Tumor burden in the proximal, middle, and distal portions of the small intestine and colon. Tumor burden was calculated using the formula (4/3)pr 3 . *P \ 0.05; **P \ 0.005; ***P \ 0.001. n = 15 for Apc Min/? mice and n = 18 for Apc D242/? mice. Error bars represent standard deviation
The oligomerization domain allows Apc proteins to interact with one another. Initial studies on the role of Apc as an oncogene focused on potential dominant negative effects of truncated Apc proteins. Studies have demonstrated that truncated Apc mutants can sequester full-length Apc proteins and this interaction could potentially block formation of the Apc-Axin-GSK3b negative regulatory complex (reviewed in Aoki and Taketo 2007) . In addition to preventing formation of the regulatory complex, sequestration of full-length Apc results in improper formation of the mitotic spindle and errors in chromosomal segregation (Green et al. 2005) . These data may explain the presence of Apc mutations at the earliest stages of adenoma development. The presence of the mutant Apc product results in chromosomal instability and increases the probability of the cell acquiring further genetic lesions (Fodde et al. 2001) . The Apc D242 protein should still be capable of acting as a dominant negative due to the presence of the oligomerization domain. The observed increase in tumor multiplicity compared to Apc Min/? mice could be the result of increased binding affinity between full-length Apc and truncated Apc mutants in which the armadillo repeats are absent.
The increased polyposis in Apc D242/? mice compared to Apc Min/? , Apc D474 , and Apc D580 mice more likely results from the loss of the armadillo repeat domain (Fig. 2) . These repeats are involved in protein-protein interactions and there is conflicting evidence regarding the role of this domain in tumorigenesis (Barth et al. 2002) . The human APC protein associates with the ends of microtubules during active cell migration, suggesting a role for APC in regulating migration (Mogensen et al. 2002) . APC binds both the guanine nucleotide exchange factor ASEF and the GTPase effector IQGAP1, which in turn decrease cell adhesion and increase migration (Kawasaki et al. 2000; Watanabe et al. 2004 ). These protein-protein interactions occur via the armadillo repeat domain; truncated APC generated by MCR mutations is still able to activate ASEF, suggesting an oncogenic potential for the armadillo repeats (Kawasaki et al. 2000 (Kawasaki et al. , 2003 . In vivo data, however, demonstrate that B6 Apc Min/? mice have decreased migration rates of intestinal cells along the crypt-villus axis compared to wild-type B6 mice (Javid et al. 2005) . Other experiments have shown that the armadillo repeats are required for normal cell migration along the cryptvillus axis and indicate that the domain may have a tumor suppressive role (Kawasaki et al. 2003) . Maintenance of the crypt-villus axis is essential for homeostasis in the intestinal tract. Cells of the gut are exposed to carcinogens present in the intestinal lumen and frequent turnover of intestinal epithelial cells serves as a protective mechanism. Dysregulation of cell migration along this axis can cause the accumulation of cells carrying genetic lesions and result in tumor initiation (Mahmoud et al. 1999) . If the armadillo repeat domain of Apc is required for proper cell migration, loss of this domain in Apc D242/? mice may result in increased tumorigenesis by disrupting cell turnover in intestinal crypts.
The specific roles of the oligomerization and armadillo repeat domains in intestinal tumorigenesis have not been fully dissected in an in vivo system. Here we demonstrate in a novel mouse model that complete loss of the armadillo repeats results in increased tumorigenesis in all parts of the small intestine. Our data demonstrate that Apc D242/? mice are a model of severe FAP, developing significantly more tumors than Apc Min/? mice while showing no increases in average tumor size or stage. These data suggest that the loss of the armadillo repeats region results in increased tumor initiation, implying an unknown tumor suppressive function of the armadillo repeats. Further comparative analyses between Apc Min/? and Apc D242/? mice can dissect the respective roles of the oligomerization domain and the armadillo repeats. Future work must focus on integrating the in vivo and in vitro data to better understand the function of the armadillo repeats.
